Saura Inês, Silva Joana Brandão, Cunha Daniela, Ramos Iliana, Semedo Valéria, Andrade José Paulo, Dourado Marília, Ribeiro Hugo
Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.
Health Family Unit Aldeias do Xisto, Local Health Unit of Coimbra, 3004-561 Coimbra, Portugal.
J Clin Med. 2025 Aug 31;14(17):6167. doi: 10.3390/jcm14176167.
Anorexia-Cachexia Syndrome (ACS) is a multifactorial condition common in advanced chronic illnesses, leading to significant impacts on prognosis and quality of life. This retrospective cohort study aimed to evaluate the prevalence, management strategies, and clinical and patient-centered outcomes of ACS in a home-based palliative care team. Clinical records of 128 adult patients followed between 2021 and 2024 were analyzed. Data collected included sociodemographic variables, clinical diagnosis, nutritional parameters (Palliative Performance Scale (PPS), Mini Nutritional Assessment (MNA)), symptoms (anorexia, fatigue), interventions (enteral nutrition, psychological and rehabilitative support), and relevant medications. Statistical analysis included descriptive, inferential, and multivariable proportional hazard regression analysis to identify independent predictors of weight loss and anorexia. Manifestations of ACS were observed across both oncologic and non-oncologic conditions. The prevalence of weight loss and anorexia were interrelated and were not different between diagnostic groups. Using multivariable analysis, higher baseline MNA scores (HR = 3.797, = 0.006) and the use of enteral nutrition (HR = 7.418, = 0.014) were independently associated with an increased risk of significant weight loss. Lower baseline PPS scores (HR = 0.069), use of enteral nutrition (HR = -0.890), and the presence of psychological support were protective for subsequent anorexia. Dexamethasone use was associated with greater nutritional decline in univariate models. The management of ACS in home palliative care requires the early identification of symptoms, multidisciplinary intervention, and personalized strategies beyond disease etiology. Risk of weight loss is associated with higher MNA scores, and these are best managed in the first week. In anorexia cases, psychological support is protective.
厌食-恶病质综合征(ACS)是一种在晚期慢性疾病中常见的多因素病症,对预后和生活质量有重大影响。这项回顾性队列研究旨在评估居家姑息治疗团队中ACS的患病率、管理策略以及临床和以患者为中心的结局。分析了2021年至2024年期间随访的128例成年患者的临床记录。收集的数据包括社会人口统计学变量、临床诊断、营养参数(姑息治疗表现量表(PPS)、微型营养评定法(MNA))、症状(厌食、疲劳)、干预措施(肠内营养、心理和康复支持)以及相关药物。统计分析包括描述性、推断性和多变量比例风险回归分析,以确定体重减轻和厌食的独立预测因素。在肿瘤和非肿瘤病症中均观察到了ACS的表现。体重减轻和厌食的患病率相互关联,且在诊断组之间无差异。通过多变量分析,较高的基线MNA评分(HR = 3.797, = 0.006)和肠内营养的使用(HR = 7.418, = 0.014)与显著体重减轻风险增加独立相关。较低的基线PPS评分(HR = 0.069)、肠内营养的使用(HR = -0.890)以及心理支持的存在对随后的厌食具有保护作用。在单变量模型中,地塞米松的使用与更大的营养衰退相关。居家姑息治疗中ACS的管理需要早期识别症状、多学科干预以及超越疾病病因的个性化策略。体重减轻风险与较高的MNA评分相关,这些最好在第一周进行管理。在厌食病例中,心理支持具有保护作用。